1. The **Capital One** for store-branded credit cards and consumer financing programs, working behind the scenes for hundreds of retailers and healthcare providers.

2. It's like **Affirm** or **Klarna**, but for a much wider range of traditional private label credit cards and installment loans, partnered with numerous retailers and healthcare providers.

3. A specialized bank that acts as the outsourced credit and financing arm for a vast network of retailers and healthcare providers, similar to how a large payroll company like **ADP** manages payroll for many different businesses.

• Credit Cards: Provides a range of credit cards, including private label, co-brand, dual, and general purpose cards.
• Consumer & Commercial Installment Loans: Offers short-term and long-term installment loans to both consumers and commercial clients.
• Deposit Products: Accepts deposits through various accounts such as certificates of deposit, individual retirement accounts, money market accounts, and savings accounts.
• Specialized Financing Solutions: Delivers payments and financing programs tailored for specific industries like healthcare, retail, home, auto, and point-of-sale purchases.
• Debt Cancellation Products: Offers debt cancellation options to its eligible credit card customers.

Synchrony Financial (SYF) primarily sells its credit products and financing solutions to other companies, which then offer these to their own customers. Therefore, its major customers are the businesses with which it establishes programs and partnerships.

Based on the provided background, Synchrony Financial's major customers and partners include:

• Walgreens (WBA): Synchrony provides healthcare payments and financing solutions under the Walgreens brand.
• National and Regional Retailers: This includes a broad group of retailers in various industries such as apparel, specialty retail, home, auto, powersports, jewelry, and luxury.
• Local Merchants: Synchrony partners with local businesses across different sectors.
• Manufacturers: The company establishes programs with manufacturers.
• Healthcare Service Providers: This category includes providers of audiology products, dental services, and other health and wellness service providers.
• Buying Groups and Industry Associations: Synchrony also forms programs with these types of organizations.

Brian Doubles, President and Chief Executive Officer

Brian Doubles was named CEO in April 2021, after serving as President for two years and as Executive Vice President and Chief Financial Officer for 10 years, including the period prior to Synchrony's separation from GE in 2014. He played a pivotal role in Synchrony's initial public offering in 2014 and its separation from GE in 2015. Prior to Synchrony's founding, he held various roles of increasing responsibility and management at GE, starting in 1998, across audit, treasury, consumer finance, and financial planning and analysis.

Brian Wenzel, Executive Vice President, Chief Financial Officer

Brian Wenzel is the Executive Vice President and Chief Financial Officer for Synchrony, appointed to this role in May 2019. He oversees accounting and controllership, financial planning and analysis, tax, investor relations, and treasury. He has over 30 years of experience in financial and strategic management, including 21 years at Synchrony and its predecessor, GE. Before becoming CFO, he was Synchrony's Deputy Chief Financial Officer and previously served as the CFO of Synchrony's Retail Card platform. Earlier in his career, he held roles in business development, growth, and investments for Synchrony and for GE's Treasury and Global Funding Operation. Before joining GE, Brian worked for PricewaterhouseCoopers and held various roles in a start-up healthcare venture.

Carol Juel, Executive Vice President, Chief Technology and Operating Officer

Carol Juel is Executive Vice President, Chief Technology and Operating Officer of Synchrony. She is responsible for building Synchrony's technology and operations strategy, creating seamless customer experiences, and driving the company's operational approach and engagement with cardholders. Prior to this role, she was Synchrony's first Chief Information Officer. Before Synchrony's separation from GE in 2015, Carol served as Chief Information Officer of GE Capital Retail Finance. In her ten years with GE, she held various senior leadership roles in technology governance, security, business development, digital, and marketing. She also spent nearly a decade in technology consulting at Accenture, focusing on the financial services sector.

Alberto Casellas, Executive Vice President and CEO—Health & Wellness

Alberto (Beto) Casellas is Executive Vice President and Chief Executive Officer of the Health & Wellness platform at Synchrony, a role held since June 2021. In this role, he drives growth through healthcare payments and financing solutions, overseeing CareCredit and Pets Best. Prior to this, he served as Executive Vice President and Chief Customer Engagement Officer of Synchrony, focusing on customer engagement and analytics. He began his career at GE in 1990, holding leadership assignments in sales, operations, P&L leadership, and e-commerce across various GE businesses, including GE Supply, GE Structured Services, and GE Capital.

Bart Schaller, Executive Vice President and CEO—Digital

Bart Schaller is Executive Vice President and Chief Executive Officer of the Digital platform at Synchrony, a position he has held since June 2021. In this role, he is responsible for providing comprehensive payment and financing solutions to partners and merchants primarily engaging with consumers through digital channels. Prior to this, he served as Chief Marketing Officer of Synchrony from May 2016 to June 2021, and before that, he led Synchrony's Business Development team from March 2014 to May 2016, overseeing new partner programs, sales, strategic investments, and M&A opportunities. Prior to Synchrony's separation from GE, he was Vice President and General Manager for GE Retail Consumer Finance from February 2005 to March 2014.

The key risks to Synchrony Financial (SYF) primarily revolve around its exposure to consumer credit, the evolving regulatory landscape, and increasing competition within the financial services sector.

1. Credit Risk and Macroeconomic Conditions: Synchrony Financial's performance is highly sensitive to macroeconomic conditions, including consumer confidence, unemployment rates, and inflation. As a consumer financial services company, its profitability is directly impacted by consumers' ability to make payments on their credit products. Rising interest rates can lead to increased delinquencies and higher charge-offs on credit card and loan portfolios. The company historically operates with a higher default rate compared to many traditional banks, necessitating higher loss reserves, and its net interest margin is vulnerable to credit quality concerns.
2. Regulatory and Political Risk: Synchrony Financial operates in a heavily regulated environment, and changes in government policies or consumer protection regulations pose a significant risk. Recent concerns include potential federal interest rate caps on credit cards, which could fundamentally alter the risk-based pricing model of the credit card industry and negatively impact Synchrony's net interest margin and profitability. Investigations by bodies like the Consumer Financial Protection Bureau (CFPB) can also lead to financial penalties and reputational damage.
3. Competition and Evolving Payment Landscape: The consumer financial services industry is intensely competitive, with threats emerging from various players, including traditional banks, fintech companies, and Buy Now, Pay Later (BNPL) providers. Synchrony must continuously innovate and adapt to maintain its market position against new technologies and entrants. The rise of alternative payment methods and "agentic commerce" could challenge traditional interchange fee models, impacting revenue streams for credit card issuers like Synchrony.

The rapid adoption and expansion of Buy Now, Pay Later (BNPL) services, including offerings from fintech companies (such as Affirm, Klarna, and Afterpay) and major technology platforms (such as Apple Pay Later). These services provide consumers with alternative, often interest-free or low-interest, installment payment options directly at the point of sale. This model directly competes with Synchrony Financial's core private label credit card and consumer installment loan products offered through its extensive network of retail, healthcare, and other merchant partners, challenging Synchrony's established business model of providing traditional revolving credit and financing solutions.

Synchrony Financial operates in several key addressable markets within the United States, primarily focusing on consumer financing through credit products and specialized payment solutions.

U.S. Addressable Markets for Synchrony Financial's Main Products and Services:

• Private Label Credit Cards: The purchase volume for private label credit cards in the U.S. reached $201.20 billion in 2023. This market is projected to grow, with an anticipated purchase volume of $377.8 billion and receivables of $163.9 billion by 2027. Synchrony Financial itself targets over $339 billion in purchases and $172 billion in outstandings in this segment by 2025.
• Co-brand Credit Cards: The global co-branded credit card market was estimated at $13.41 billion in 2023 and is projected to reach $25.72 billion by 2030. Another estimate indicates the global market size was USD 16.00 billion in 2025, reaching USD 17.55 billion in 2026 and projected to grow to USD 31.28 billion by 2032. The U.S. is a significant contributor to this market.
• Consumer Installment Loans/Personal Loans: Personal loans in the U.S. amounted to $356 billion by the end of 2022. The broader U.S. loan market was valued at USD 1123.45 billion in 2024 and is expected to reach USD 1872.45 billion by 2030. The North American personal loans market was valued at USD 172.44 billion in 2025 and USD 192.13 billion in 2026.
• Healthcare Payments and Financing Solutions (including CareCredit): The U.S. healthcare finance solutions market was valued at USD 46.1 billion in 2021 and is expected to expand to USD 89.8 billion by 2030. Another report estimates the U.S. market at USD 51.94 billion in 2024, projected to reach USD 95.54 billion by 2032. CareCredit, a Synchrony Financial subsidiary, is a leading provider in this space, with 11.7 million cardholders in 2023. The CareCredit card is accepted at over 285,000 healthcare provider and retail locations nationwide and has over 12 million cardholders with approximately $40 billion in available credit.
• Dental Services Market (a component of healthcare financing): The U.S. dental services market was valued at USD 130.30 billion in 2022 and is projected to reach USD 216.33 billion by 2030. Other estimates place the U.S. dental services market at approximately USD 174.2 billion in 2025, growing to USD 234.11 billion by 2031, or USD 184.57 billion in 2025, reaching USD 308.65 billion by 2035. Another valuation states the U.S. dental services market size at US$166.5 billion in 2024, growing to US$172.6 billion in 2025, and projected to reach US$254.7 billion by 2034.
• Audiology Products and Services Market (a component of healthcare financing): The U.S. audiology devices market generated revenue of USD 4,297.6 million in 2024 and is expected to reach USD 5,905.8 million by 2030. The North American audiology devices market holds the largest global share, with the U.S. accounting for over 35% of global revenue in 2024. The audiology services market in the U.S. was valued at USD 12,055.85 million in 2025 and is expected to grow to USD 17,984.38 million by 2032.
• Pet Care Market (including Pets Best financing solutions): The U.S. pet care market is valued at USD 152 billion based on a five-year historical analysis (as of November 2025). This market is projected to reach $157 billion in the U.S. in 2025. The U.S. pet care and services market is expected to grow from USD 62.1 billion in 2025 to USD 91.74 billion by 2031. The U.S. pet insurance market alone surpassed $4.7 billion in 2024.

Capital Allocation Decisions for Synchrony Financial (SYF)

Share Repurchases

• Synchrony Financial had significant share repurchases in recent years, with $3.32 billion in 2022, $1.112 billion in 2023, and $1.008 billion in 2024.
• In April 2022, the company authorized an incremental share repurchase program of up to $2.8 billion through June 30, 2023, bringing the total authorization to approximately $3.1 billion.
• An additional $1.3 billion share repurchase authorization was approved in April 2023, commencing through June 30, 2024, which included approximately $300 million remaining from a prior program. More recently, in October 2025, the Board approved a $1 billion increase to its share repurchase authorization, extending the program through June 30, 2026, making $2.1 billion available for repurchases.

Share Issuance

• Synchrony Financial has consistently reduced its outstanding shares over the last few years, indicating no significant share issuances. The number of shares outstanding declined by 6.67% in 2025 to 0.374 billion, by 5.41% in 2024 to 0.401 billion, and by 12.39% in 2023 to 0.424 billion from the previous year.

Inbound Investments

• Information regarding large inbound investments made in Synchrony Financial by third-parties is not readily available within the provided data.

Outbound Investments

• In 2023, Synchrony made an outbound investment by taking a minority ownership stake in Independence Pet Holdings (IPH) as part of a strategic partnership. This agreement also involved IPH acquiring Pets Best, a pet insurance company Synchrony had acquired in 2019.

Capital Expenditures

• Synchrony Financial's investments include technology, with "technology investments" contributing to a 3% increase in "Other Expense" to $1.2 billion in Q1 2025.
• The company is focused on maintaining investments for long-term success, particularly in advanced analytics, AI, and embedded finance, to enhance operational efficiency, mitigate risk, and promote sustainable growth across diverse markets.